Stock Events

Arrowhead Pharmaceuticals (A2RR34.SA) Q2 2020 Earnings

7MayConfirmed
Q3 2019
Q4 2019
Q1 2020
Q2 2020
-1.17
-0.29
0.59
1.47

Details

Expected EPS
-0.5831050000000001
Actual EPS
-1.1662100000000002
Surprise EPS
-0.58
Surprise Percent
+100%

Description

Arrowhead Pharmaceuticals (A2RR34.SA) has reported earnings of -1.1662100000000002 per share for Q2 2020.

0 Comments

Share your thoughts